4-(4-chlorobenzyl)-2-(perhydroazepinyl-(4))-1(2H)-phthala zinone,
desmethylazelastine,
desmethylazelastine hydrobromide,
Desmethylazelastine,
N-Desmethyl Azelastine,
47491-38-3,
CHEMBL2074921,
1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1H-azepin-4-yl)-,
1(2H)-Phthalazinone,4-[(4-chlorophenyl)methyl]-2-(hexahydro-1H-azepin-4-yl)-,
4-[(4-CHLOROPHENYL)METHYL]-2-(HEXAHYDRO-1H-AZEPIN-4-YL)-1(2H)-PHTHALAZINONE,
Demethylazelastine,
AC1Q3NQW,
AC1L4RI0,
SCHEMBL2820100,
CTK4J0036,
WRYCMIFVXDQIKN-UHFFFAOYSA-N,
4-(4-Chlorobenzyl)-2-(perhydroazepinyl-(4))-1(2H)-phthalazinone,
ANW-42345,
BDBM50420234,
AKOS030254511,
ACM47491383,
FT-0666081,
2-(azepan-4-yl)-4-(4-chlorobenzyl)phthalazin-1(2H)-one,
2-(azepan-4-yl)-4-[(4-chlorophenyl)methyl]phthalazin-1-one,
4-(4-chlorobenzyl)-2-(hexahydroazepin-4-yl)-1-(2H)-phthalazinone,
4-[(4-chlorophenyl)methyl]-2-(hexahydro-1H-azepin-4-yl)-l (2H)-phthalazinone,
UNII-8W9SOB28Q4,
desmethylazelastine hydrobromide,
8W9SOB28Q4,
C21-H22-Cl-N3-O,
KST-1B5268,
KST-1B5269,
AR-1B0858,
AR-1B0859,
CID162558,
CS-O-06068,
C054114,
4-(4-Chlorobenzyl)-2-(perhydroazepinyl-(4))-1(2H)-phthala zinone,
5440-04-0,
54400-59-8,